Sutro Biopharma
STRO
#8442
Rank
A$0.24 B
Marketcap
$3.00
Share price
3.30%
Change (1 day)
-51.24%
Change (1 year)

Sutro Biopharma (STRO) - Cash on Hand

Cash on Hand as of September 2024 : A$0.62 Billion

According to Sutro Biopharma's latest financial reports the company has A$0.62 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sutro Biopharma - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.49 B79.96%
2021-12-31A$0.27 B-42.97%
2020-12-31A$0.47 B184.4%
2019-12-31A$0.16 B-42.01%
2018-12-31A$0.29 B929.15%
2017-12-31A$28.2 M-57.22%
2016-12-31A$65.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$26.19 M-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.64 B 4.67%๐Ÿ‡บ๐Ÿ‡ธ USA